Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gentle Tears is an over-the-counter ophthalmic solution developed and manufactured by Euro-Med Laboratories Phil., Inc. It is formulated as artificial tears, typically containing hypromellose (hydroxypropyl methylcellulose) as the active lubricant. The solution functions by increasing the viscosity of the tear film and prolonging the tear break-up time, thereby providing a protective and lubricating layer over the corneal epithelium. It is primarily indicated for the symptomatic relief of dry eye syndrome (keratoconjunctivitis sicca) and ocular irritation caused by environmental factors such as wind, sun, or prolonged screen use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gentle Tears.